Interferon-α and pericardial injury: a case report and literature review.
Interferon- α (IFN-α) alone or in combination with other chemotherapeutic agents has been used in the management of many malignant and non-malignant conditions. Pericarditis with or without pericardial effusion has been reported with IFN-α therapy, and available literature is limited to case reports. Pericardial constriction after interferon use has not been described in the published literature to date. We performed a systematic review of literature to address the demographic features, clinical presentation, diagnosis, treatment and outcome of interferon-related pericardial injury.
Department of Cardiovascular Diseases, Scottsdale, Arizona , USA.
Fayaz A
FA
Hakim
Internal Medicine, Scottsdale, Arizona , USA.
Sujata
S
Singh
Department of Cardiovascular Diseases, Scottsdale, Arizona , USA.
Anil
A
Pandit
Department of Cardiovascular Diseases, Scottsdale, Arizona , USA.
Jorge R
JR
Alegria
Hematology-Oncology, Scottsdale, Arizona , USA.
John
J
Camoriano
Laboratory Medicine and pathology , Mayo Clinic , Scottsdale, Arizona , USA.
Melissa L
ML
Stanton
Department of Cardiovascular Diseases, Scottsdale, Arizona , USA.
Farouk
F
Mookadam